SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis.

Cited by papers we hold 5

• Novel Role of the SIRT1 in Endocrine and Metabolic Diseases · 2023
  No notice
• Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review · 2023
  No notice
• The sirtuin family in health and disease · 2022
  No notice
• The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis · 2021
  No notice
• The Role and Mechanism of SIRT1 in Resveratrol-regulated Osteoblast Autophagy in Osteoporosis Rats · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.